SEC Form 4 · accession 0001144204-15-000639
CALADRIUS BIOSCIENCES, INC. · CLBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David J Mazzo
Officer — Chief Executive Officer · Director
Period of report
Jan 5, 2015
Accepted (ET)
Jan 5, 2015 · 9:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000320017
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to purchase)F1 | $3.50 | Jan 5, 2015 | A | 620,000 | A | — | Jan 4, 2025 | Common Stock, par value $0.001 per share | 620,000 | 620,000 | D |
| Stock Option (right to purchase)F2 | $3.50 | Jan 5, 2015 | A | 200,000 | A | — | Jan 4, 2025 | Common Stock, par value $0.001 per share | 200,000 | 200,000 | D |
Explanation of responses
- F1On January 5, 2015, the commencement date (the "Commencement Date") of his employment with NeoStem, Inc. (the "Company"), the reporting person, David J. Mazzo, Ph.D., was granted an option (the "Initial Option") to purchase 620,000 shares of the Company's common stock, par value $0.001 per share ("Common Stock"), pursuant and subject to the terms and conditions of the Company's Amended and Restated 2009 Equity Compensation Plan (the "2009 Plan"). The Initial Option was vested as to 100,000 shares immediately upon grant with the remainder of the Initial Option shares scheduled to vest subject to Dr. Mazzo's continued employment in a series of sixteen successive quarterly installments (32,500 shares each) over the four years following the Commencement Date.
- F2Additionally, on the Commencement Date, Dr. Mazzo was granted an additional option (the "Additional Option") to purchase 200,000 shares of Common Stock, pursuant and subject to the terms and conditions of the 2009 Plan. The Additional Option provides for vesting based on two individual milestones (100,000 Additional Option shares each) to be mutually established by the Compensation Committee (or the Executive Chairman) and Dr. Mazzo within three months following the Commencement Date subject to Dr. Mazzo's continued employment on each of the applicable 1/16th milestone vesting dates.